Crinetics Pharmaceuticals Inc reports results for the quarter ended in January - Earnings Summary

Crinetics Pharmaceuticals

10/05/2024 02:40

* Crinetics Pharmaceuticals Inc  CRNX.OQ  reported a
quarterly
adjusted loss of 93 cents​​ per share for the quarter ended in
January, lower than the same quarter last year, when the company
reported EPS of -85 cents.  The mean expectation of
twelve analysts for the quarter was for a loss of 81 cents per
share. Wall Street expected results to range from -94 cents
to -68 cents per share.
    * Revenue fell 76.1% to $640.00 thousand from a year ago;
analysts
expected $255.56 thousand. 
    * Crinetics Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 93 cents​.
    * The company reported a quarterly loss of $66.93 million.
    * Crinetics Pharmaceuticals Inc shares had risen by 8.7%
this
quarter and gained 43.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 7.2%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Crinetics
Pharmaceuticals Inc is $57.00 
This summary was machine generated from LSEG data May 10 at
01:40 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.81          -0.93          Missed
 Dec. 31 2023      -0.86          -0.90          Missed
 Sep. 30 2023      -0.86          -1.01          Missed
 Jun. 30 2023      -0.86          -0.94          Missed